The results showed increased tumor cell invasiveness with increasing sclerostin concentration, with only the higher dose of sclerostin (5 ng/mL) showing a statistically significant result (p < 0.05), as shown in Figure 5b. This evidence concerns the gene SOST and neoplasm.